Company Financials

Cytek Biosciences, Inc. Financials

United States dollar

business Cytek Biosciences, Inc. Company Profile

Main Stock Listing

NASDAQ: CTKB

Market Capitalization None as of None

Market Cap History

Valuations Metrics as of May. 5, 2024

Trailing PE 374.50
Forward PE 62.20
Price to Sales TTM $4.23
Price to Book MRQ $2.07
Enterprise to Revenue 2.93
Enterprise to EBITDA -27.86

Financial Reports as of Dec. 31, 2023

Financials

Fiscal Year Ends 2023-12-31
Most Recent Quarter 2023-12-31
Profit Margin -6.29%
Operating Margin -0.24%
Return on Assets TTM -3.25%
Return on Equity TTM -2.97%

Income Statement

Revenue TTM $193,015,008
Revenue per Share TTM $1.43
Quarterly Revenue Growth 20.50%
Gross Profit TTM $109,426,000
EBITDA $-20,297,000
Net Income to Common TTM $-12,148,000
Diluted EPS TTM $-0.09
Quarterly Earnings Growth YoY 64.50%

Balance Sheet

Total Cash MRQ $262,410,000
Total Cash per Share MRQ $2.01
Total Debt MRQ $
Total Debt to Equity MRQ 3.60
Current Ratio MRQ 6.97
Book Value per Share MRQ $3.01

Cash Flow

Operating Cash Flow TTM $5,281,000
Levered Free Cash Flow TTM $-400,000

CTKB Stock Info as of May. 5, 2024

Stock Statistics

Shares Outstanding 131,264,000
Float Shares 105,810,507
Avg 10 Volume 564,150
Avg 30 Volume None
Shares Short 7,471,493
Short Ratio 10.02
Short % of Shares 7.29%
% Held by Insiders 8.67%
% Held by Institutions 65.11%

Stock Price Summary

Beta 1.37
Fifty Two Week Low $3.80
Fifty Two Week High $11.88
Fifty Two Week Change -86.50%
Day 50 MA $6.81
Day 200 MA $7.18

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date